Direct Flow Medical, Inc.
451 Aviation Boulevard
Suite 107A
Santa Rosa
California
95403
United States
Tel: 707-576-0420
Fax: 707-576-0430
Website: http://www.directflowmedical.com/
Email: info@directflowmedical.com
About Direct Flow Medical, Inc.
Direct Flow Medical, Inc. (www.directflowmedical.com), a privately held medical device company developing a next generation, minimally invasive implant to treat patients with heart valve disease. The Company has developed a catheter-based system to replace the aortic valve percutaneously in patients with valvular disease. The device is an implantable, non-metallic pericardial tissue valve that allows delivery via a transfemoral approach. The product’s unique features are intended to allow precise positioning , repositioning and retrieval, enabling physicians to correctly size and place the device in its targeted location providing a new level of safety for the patient. The device is intended for investigational use only outside the United States. The device is not available for sale in or outside the United States.39 articles about Direct Flow Medical, Inc.
-
Bay Area Direct Flow Medical Shuts Down, 250 People Laid Off
12/22/2016
-
Direct Flow Medical Banks $27 Million
7/25/2016
-
Direct Flow Medical Announces DISCOVER Trial Three-Year Results
5/20/2016
-
Direct Flow Medical Strengthens SALUS Pivotal Trial
4/28/2016
-
Direct Flow Medical Bags $31 Million for Heart Valve Programs
4/15/2016
-
Direct Flow Medical, Inc. Launches Next Generation TAVI Delivery System
3/28/2016
-
Direct Flow Medical, Inc. Announces D. Scott Lim, MD, As New Co-Principal Investigator For U.S. SALUS Pivotal Trial
10/27/2015
-
Direct Flow Medical, Inc. Release: Post-Market Study Of Direct Flow Medical Transcatheter Aortic Valve System For Tavr Demonstrates Excellent One-Year, Real World Results
10/15/2015
-
Direct Flow Medical, Inc. Appoints Mary Edwards As Vice President, Regulatory And Clinical Affairs
8/26/2015
-
Isaac George, MD, Named Co-Principal Investigator For U.S. Salus Pivotal Trial Of Direct Flow Medical, Inc. Transcatheter Heart Valve System
6/4/2015
-
Results From Post-Market Study Of The Direct Flow Medical, Inc. Aortic Heart Valve System Demonstrate Consistently Positive Outcomes At 30 Days
5/20/2015
-
Direct Flow Medical, Inc. Reports Excellent Two Year Data For Its Transcatheter Aortic Heart Valve System
5/19/2015
-
Direct Flow Medical, Inc. Names Daniel Lemaitre As Chief Executive Officer
5/8/2015
-
Direct Flow Medical, Inc. Appoints W. Randolph Chitwood, MD, As Director Of Surgeon Relations
4/23/2015
-
Direct Flow Medical, Inc. Announces FDA Approval To Broaden SALUS U.S. Pivotal Trial
4/9/2015
-
Direct Flow Medical, Inc. Announces New Financing Of $32 Million Company Also Appoints Chief Commercial Officer
12/5/2014
-
Direct Flow Medical, Inc. Receives CE Mark For An Enhanced And Simple To Use Transfemoral Aortic Heart Valve Delivery System
10/2/2014
-
Direct Flow Medical, Inc. Receives CE Mark For 23mm Valve And For Implantation Of All Sizes Of Its Transcatheter Aortic Heart Valve Without Use Of Contrast
8/21/2014
-
Direct Flow Medical, Inc. Transcatheter Aortic Valve System Demonstrates Excellent 12 Month Outcomes In DISCOVER CE Mark Trial
5/22/2014
-
Direct Flow Medical, Inc. Lands $50 Million, Poised To Nearly Double In Size
2/18/2014